Long term results of growth hormone treatment in France in children of short stature: Population, register based study

British Medical Journal

Volumn 315, Issue 7110, 1997, Pages 708-713

  Coste, Joël ^a,b   Letrait, Muriel ^a   Carel, Jean Claude ^c   Tresca, Jean Pierre ^a,b   Chatelain, Pierre ^b,c   Rochiccioli, Pierre ^b,c   Chaussain, Jean Louis ^b,c   Job, Jean Claude ^b,c  

^a Hôpital Cochin ^*  (France)

^b Department of Biostatistics ^*

^c Association France Hypophyse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ARTICLE; BODY HEIGHT; CHILD; DELAYED PUBERTY; DRUG COST; FATIGUE; FEMALE; FRANCE; GROWTH HORMONE DEFICIENCY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REGISTER; SHORT STATURE; TURNER SYNDROME;

EID: 0030806544     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7110.708     Document Type: Article

References (32)

1. Burns EC, Tanner JM, Preece MA, Cameron N. Growth hormone treatment in craniopharyngioma: final growth stature. Clin Endocrinol 1981;14:587-95.
2. Burns EC, Tanner JM, Preece MA, Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr 1981;137:155-64.
3. Job JC, Chicaud J, Toublanc JE, Chaussain JL. Le devenir à long terme des nains hypophysaires traités par hormone de croíssance. Arth Fr Pédiatr 1988;45:169-73.
4. Hibi I, Tanaka T. Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Acta Endocrinol 1989;120:409-15.
5. Brämswig JH, Schlosser H, Kiese K. Final height in children with growth hormone deficiency. Horm Res 1995;43:126-8.
6. Chipman JJ, Hick JR, Holcombe JH, Draper MW. Approaching final height in children treated for growth hormone deficiency. Horm Res 1995;43:129-31.
7. Frisch H, Birnbacher R. Final height and pubertal development in children with growth hormone deficiency after long-term growth hormone treatment. Horm Res 1995;43:132-4.
8. Severi F. Final height in children with growth hormone deficiency. Horm Res 1995;43:138-40.
9. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A. Factors predicting the response to growth hormone therapy in prepubertal children with growth hormone deficiency. J Clin Endocrinol Metabol 1993;76:574-9.
10. Van den Broek J, Vanderschueren-Lodeweyck M, Eggermont E. Prediction of final height in boys with non-tumorous hypopituitarism. Eur J Pediatr 1988;147:245-7.
11. Ranke MB, Linberg A, Guilbaud O. Prediction of growth in response to treatment with growth hormone. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J und J Verlag, 1994.
12. Maes M, Lindberg A, Price DA, Albertsson-Wikland K, Ranke MB. Long-term growth response to growth hormone therapy in prepubertal children with idiopathic growth hormone deficiency: analysis of the Kabi international growth study. Kabi International Growth Study 1994;11: 15-26.
13. Price DA, Ranke MB. Final height following growth hormone treatment. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J und J Verlag, 1994.
14. Van den Broek J, Massa GG, Attanasio A, Matranga A, Chaussain JL, Price DA, et al. Final height after long-term growth treatment in Turner syndrome. J Pediatr 1995;127:729-35.
15. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. New York: Stanford University Press, 1970.
16. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Childh 1969;44:291-303.
17. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Childh 1970;45:13-24.
18. Cole T. Methodology for the analysis of longitudinal height data during puberty. Kabi International Growth Study 1993;10:37-44.
19. Sempé M, Pedron G, Roy-Perriot. Auxologie, méthodes et séquences. Paris: Théraplix, 1979.
20. Sempé P, Sempé M. Croissance et maturation osseuse. Paris: Théraplix, 1971.
21. Ranke MB. Towards a consensus on the definition of idiopathic short stature. Horm Res 1996; 45(suppl 2):64-6.
22. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age. Revised for use with the Greulich-Pyle hand standards. J Pediatr 1952;40:423-41.
23. Bland JM, Altman DG. Regression towards the mean. BMJ 1994;308:1499.
24. SAS Institute. SAS user's guide: statistics. Version 6. Cary, NC: SAS Institute, 1990.
25. Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, et al. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone treated growth hormone-deficient children. J Clin Endocrinol Metab 1989;69:221-6.
26. Bergman U. Pharmacoepidemiological perspectives. J Clin Epidemiol 1992;45:313-7.
27. Greco L, Power C, Peckham. Adult outcome of normal children who are short or underweight at age 7 years. BMJ 1995;310:696-700.
28. Hindmarsh PC, Brook CGD. Final height of short normal children treated with growth hormone. Lancet 1996;348:13-6.
29. Carel JC, Hay F, Coutant R, Rodrigue D, Chaussain JL. Gonadotrophin releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development. J Clin Endocrinol Metab 1996;81:3318-22.
30. Allen DB, Frost NC. Growth hormone therapy for short stature: a panacea or Pandora's box? J Pediatr 1990;117:16-21.
31. Cacciari E, Tassoni P, Cicognani A, Pirazzoli P, Salardi S, Balsamo A, et al. Value and limits of pharmacological and physiological tests to diagnose growth hormone deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinol Metab 1994;79:1663-9.
32. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SG, Hasegawa Y, Hintz RL, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-40.